MiR-122-5p Regulates the Mevalonate Pathway by Targeting p53 in Non-small Cell Lung Cancer

Investigators evaluated the role of these factors in NSCLC. The role of miR-122-5p and p53 was established in samples from NSCLC patients, and human NSCLC cells A549 using the miR-122-5p inhibitor, miR-122-5p mimic, and si-p53.